MwPharm references

MwPharm won critical acclaim in 2013 and was awarded the world's best TDM software:

Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N.: Benchmarking therapeutic drug monitoring software: a review of available computer tools. Clin Pharmacokinet. 2013 Jan;52(1):9-22. doi: 10.1007/s40262-012-0020-y.

Proost JH, Meijer DK.: MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med. 1992 May;22(3):155-63.

Neef C, Jelliffe RW, van Laar T, Loohuis T, Essink AW, Janssen EN.: Comparison of two software programs to be used for the calculation of population pharmacokinetic parameters. Int J Biomed Comput. 1994 Jun;36(1-2):143-50.

Publications

Mouton JW, Vinks AA, Punt NC.: Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion. Antimicrob Agents Chemother. 1997 Apr;41(4):733-8.

Op den Buijsch RA, van de Plas A, Stolk LM, Christiaans MH, van Hooff JP, Undre NA, van Dieijen-Visser MP, Bekers O.: Evaluation of limited sampling strategies for tacrolimus. Eur J Clin Pharmacol. 2007 Nov;63(11):1039-44. Epub 2007 Aug 22.

Alffenaar JW, Kosterink JG, van Altena R, van der Werf TS, Uges DR, Proost JH.: Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Ther Drug Monit. 2010 Feb;32(1):97-101. doi: 10.1097/FTD.0b013e3181cc6d6f.

Kerkhofs T, Derijks L, Ettaieb M, den Hartigh J, Neef C, Gelderblom H, Guchelaar HJ, Haak H.: Development of a Pharmacokinetic Model of Mitotane: Towards Personalized Dosing in Adrenocortical Carcinoma. Ther Drug Monit. 2014 May 30.

Ter Laak MA, Roos C, Touw DJ, van Hattum PR, Kwee A, Lotgering FK, Mol BW, van Pampus MG, Porath MM, Spaanderman ME, van der Post JA, Papatsonis DN, van 't Veer NE.: Pharmacokinetics of nifedipine slow-release during sustained tocolysis. Int J Clin Pharmacol Ther. 2014 Nov 19.

Boereboom FT, van Dijk A, van Zoonen P, Meulenbelt J.: Nonaccidental endosulfan intoxication: a case report with toxicokinetic calculations and tissue concentrations. J Toxicol Clin Toxicol. 1998;36(4):345-52.

Pullen J, de Rozario L, Stolk LM, Degraeuwe PL, van Tiel FH, Zimmermann LJ.: Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates. Ther Drug Monit. 2006 Jun;28(3):351-8.

Cremers SC, Scholten EM, Schoemaker RC, Lentjes EG, Vermeij P, Paul LC, den Hartigh J, de Fijter JW.: A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients. Nephrol Dial Transplant. 2003 Jun;18(6):1201-8.

Valik D, Sterba J, Bajciova V, Demlova R.: Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate. Oncology. 2005;69(3):269-72. Epub 2005 Sep 15.

Worrall SP, Almond MK, Dhillon S.: Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study. Nephron Clin Pract. 2004;97(3):c83-9.

Schreuder MF, Wilhelm AJ, Bökenkamp A, Timmermans SM, Delemarre-van de Waal HA, van Wijk JA.: Impact of gestational age and birth weight on amikacin clearance on day 1 of life. Clin J Am Soc Nephrol. 2009 Nov;4(11):1774-8. doi: 10.2215/CJN.02230409. Epub 2009 Aug 27.

Alffenaar JW, Nienhuis WA, de Velde F, Zuur AT, Wessels AM, Almeida D, Grosset J, Adjei O, Uges DR, van der Werf TS.: Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. Antimicrob Agents Chemother. 2010 Sep;54(9):3878-83. doi: 10.1128/AAC.00099-10. Epub 2010 Jun 28.

Usman M, Ashraf M, Khokhar MI, Ashiq B, Masood MI, Afzal S, Omer O, Ali M, Qadir MI.: Comparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever. Iran J Pharm Res. 2013 Winter;12(1):147-54.

Haeseker MB, Croes S, Neef C, Bruggeman CA, Stolk LM, Verbon A.: Vancomycin dosing in neutropenic patients. PLoS One. 2014 Nov 12;9(11):e112008. doi: 10.1371/journal.pone.0112008. eCollection 2014.

Haeseker M, Havenith T, Stolk L, Neef C, Bruggeman C, Verbon A.: Is the standard dose of amoxicillin-clavulanic acid sufficient? BMC Pharmacol Toxicol. 2014 Jul 21;15:38. doi: 10.1186/2050-6511-15-38.

Haeseker M, Stolk L, Nieman F, Hoebe C, Neef C, Bruggeman C, Verbon A.: The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens. Br J Clin Pharmacol. 2013 Jan;75(1):180-5. doi: 10.1111/j.1365-2125.2012.04337.x.

Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.: Pharmacokinetics of intravenous rifampicin (rifampin) in neonates. Ther Drug Monit. 2006 Oct;28(5):654-61.

Stolk LM, Degraeuwe PL, Nieman FH, de Wolf MC, de Boer A.: Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002 Aug;24(4):527-31.

Hampl J, Herzig I, Vlcek J.: Pharmacokinetics of sodium humate in chickens. Vet Med (Praha). 1994;39(6):305-13.

Kostrzewski P.: Compartment simulation models and physiologic use in pharmaco- and toxicokinetics. Med Pr. 1998;49(1):83-92. [Article in Polish]

Scopus

Alsaad, N., Dijkstra, J.A., Akkerman, O.W., De Lange, W.C.M., Van Soolingen, D., Kosterink, J.G.W., Van Der Werf, T.S., Alffenaar, J.W.C.
Pharmacokinetic evaluation of sulfamethoxazole at 800 milligrams once daily in the treatment of tuberculosis
(2016) Antimicrobial Agents and Chemotherapy, 60 (7), pp. 3942-3947.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976877588&doi=10.1128%2fAAC.02175-15&partnerID=40&md5=b4f03fc8cba4ae2f2dc60bd1d553901d
 
DOI: 10.1128/AAC.02175-15
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Khan, I.M., Khan, B.T., Najmi, M.H., Sabah, S., Ahmed, T.
Bioequivalence study of atorvastatin by HPLC with UV-detection
(2016) Rawal Medical Journal, 41 (3), pp. 354-359.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989229088&partnerID=40&md5=2fc034f0f70fc0cb6c9c308e8469f518
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Koudijs, K.K.M., Moes, D.J.A.R., Den Hartigh, J.
Interfacing MW\Pharm to a laboratory information system calculates aucs of immunosuppressants with fewer errors and in less time [Koppeling van MW\Pharm aan een laboratoriuminformatiesysteem vermindert foutgevoeligheid en verbetert efficiëntie bij berekening van concentratietijdgrafieken van immunosuppressiva]
(2015) Pharmaceutisch Weekblad, 150 (47), pp. 250-252.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951143032&partnerID=40&md5=1176a2db3afa0aeb76ab51794c7c41f4
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Grundmann, M., Kacířová, I.
Personalized pharmacotherapy of digoxin [Personalizovaná farmakoterapie digoxinem]
(2015) Vnitrni Lekarstvi, 61 (5), pp. 406-409.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84932167167&partnerID=40&md5=713cfe2a75b08d35338629c82004891b
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Grundmann, M., Kacířová, I.
TDM of digoxin in clinical practice [TDM digoxinu v klinické praxi]
(2015) Kardiologicka Revue, 17 (1), pp. 65-69. Cited 1 time.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926344521&partnerID=40&md5=880f1c235913ed590f8954894a2b7ff3
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Van Den Hurk, G.H.A.M., Janssen, J.M., Juffermans, N.P., Van Hest, R.M.
Quality of dosing recommendations during therapeutic drug monitoring of aminoglycosides at the Intensive Care Unit [De kwaliteit van doseringsadviezen bij therapeutic drug monitoring van aminoglycosiden op de intensive care]
(2015) Pharmaceutisch Weekblad, 150 (34-35), pp. 160-164.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941112067&partnerID=40&md5=7d62f3940fc0dd57aae6ece48aac6376
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Gist, K.M., Mizuno, T., Goldstein, S.L., Vinks, A.
Retrospective evaluation of milrinone pharmacokinetics in children with kidney injury
(2015) Therapeutic Drug Monitoring, 37 (6), pp. 792-796.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947904246&doi=10.1097%2fFTD.0000000000000214&partnerID=40&md5=e3fa2766922d6b42fbd899b0ed3ea76d
 
DOI: 10.1097/FTD.0000000000000214
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Haeseker, M.B., Croes, S., Neef, C., Bruggeman, C.A., Stolk, L.M.L., Verbon, A.
Vancomycin dosing in neutropenic patients
(2014) PLoS ONE, 9 (11), art. no. e112008, . Cited 4 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911440150&doi=10.1371%2fjournal.pone.0112008&partnerID=40&md5=566435e854226f885f09641349520496
 
DOI: 10.1371/journal.pone.0112008
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Liu, H., Venkatraman, S.S.
Solid/Hollow depots for drug delivery, Part 1: Effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release
(2014) Journal of Pharmaceutical Sciences, 103 (2), pp. 485-495. Cited 1 time.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895918293&doi=10.1002%2fjps.23790&partnerID=40&md5=05abd00c0367389bd4995922b92ca32a
 
DOI: 10.1002/jps.23790
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Haeseker, M., Havenith, T., Stolk, L., Neef, C., Bruggeman, C., Verbon, A.
Is the standard dose of amoxicillin-clavulanic acid sufficient?
(2014) BMC Pharmacology and Toxicology, 15 (1), art. no. 38, . Cited 6 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926111343&doi=10.1186%2f2050-6511-15-38&partnerID=40&md5=6f6dc5246f6eb14fb8f2a9bf5b8f95f0
 
DOI: 10.1186/2050-6511-15-38
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Chooi, K.W., Simão Carlos, M.I., Soundararajan, R., Gaisford, S., Arifin, N., Schätzlein, A.G., Uchegbu, I.F.
Physical characterisation and long-term stability studies on quaternary ammonium palmitoyl glycol chitosan (GCPQ) - A new drug delivery polymer
(2014) Journal of Pharmaceutical Sciences, 103 (8), pp. 2296-2306. Cited 7 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905126758&doi=10.1002%2fjps.24026&partnerID=40&md5=b2f259115ed3fc131851df93de34b8b7
 
DOI: 10.1002/jps.24026
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Usman, M., Ashraf, M., Khokhar, M.I., Ashiq, B., Masood, M.I., Afzal, S., Omer, O., Ali, M., Imran Qadir, M.
Comparative pharmacokinetics of levofoxacin in healthy volunteers and in patients suffering from typhoid fever
(2013) Iranian Journal of Pharmaceutical Research, 12 (1), pp. 147-154. Cited 2 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874685924&partnerID=40&md5=78c61391052b17e24e89c57ee0b56300
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Cabrales, A., Gil, J., Fernández, E., Valenzuela, C., Hernández, F., García, I., Hernández, A., Besada, V., Reyes, O., Padrón, G., Berlanga, J., Guillén, G., González, L.J.
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers
(2013) European Journal of Pharmaceutical Sciences, 48 (1-2), pp. 40-46. Cited 5 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869869341&doi=10.1016%2fj.ejps.2012.10.006&partnerID=40&md5=e75fa0c4cf94b87b8b312fd306beb7f2
 
DOI: 10.1016/j.ejps.2012.10.006
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Boone, N.W., Stolk, L.M.L., Degraeuwe, P.L.J., Neef, C.
Population pharmacokinetics of indometacin for prophylactic treatment of patent ductus arteriosus directly after birth of very young premature infants [Populatiekinetiek van indometacine bij profylactische behandeling van patent ductus arteriosus direct na de geboorte van zeer jonge prematuren]
(2013) Pharmaceutisch Weekblad, 148 (3), pp. 6-9.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872938102&partnerID=40&md5=1ed1689b96496adb6d0bbfe2061eb581
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Haeseker, M., Stolk, L., Nieman, F., Hoebe, C., Neef, C., Bruggeman, C., Verbon, A.
The ciprofloxacin target AUC: MIC ratio is not reached in hospitalized patients with the recommended dosing regimens
(2013) British Journal of Clinical Pharmacology, 75 (1), pp. 180-185. Cited 8 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871124488&doi=10.1111%2fj.1365-2125.2012.04337.x&partnerID=40&md5=8cea52eb9dfc223d6d7edd5146238616
 
DOI: 10.1111/j.1365-2125.2012.04337.x
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Marsot, A., Boulamery, A., Bruguerolle, B., Simon, N.
Population pharmacokinetic analysis during the first 2 years of life: An overview
(2012) Clinical Pharmacokinetics, 51 (12), pp. 787-798. Cited 17 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873456965&doi=10.1007%2fs40262-012-0015-8&partnerID=40&md5=9e2cd61f55d1e6f5f819dcabe27d1269
 
DOI: 10.1007/s40262-012-0015-8
DOCUMENT TYPE: Review
SOURCE: Scopus
 
Zahálková, J., Strojil, J., Petejová, N., Urbánek, K., Grundmann, M., Kacířová, I.
Dosage of vancomycin during continuous renal replacement therapy [Dávkování vankomycinu při kontinuální náhradě funkce ledvin]
(2011) Klinicka Farmakologie a Farmacie, 25 (3), pp. 116-120. Cited 4 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855650162&partnerID=40&md5=17c58b8a95bc90184bc972e22dadca14
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Imamura, K., Yokoyama, T., Fukushima, A., Kinuhata, M., Nakanishi, K.
Water sorption, glass transition, and protein-stabilizing behavior of an amorphous sucrose matrix combined with various materials
(2010) Journal of Pharmaceutical Sciences, 99 (11), pp. 4669-4677. Cited 5 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-78149315856&doi=10.1002%2fjps.22162&partnerID=40&md5=e6f5e381dfc16757b3757f3209cfe3ac
 
DOI: 10.1002/jps.22162
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Alffenaar, J.W.C., Nienhuis, W.A., De Velde, F., Zuur, A.T., Wessels, A.M.A., Almeida, D., Grosset, J., Adjei, O., Uges, D.R.A., Van Der Werf, T.S.
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection
(2010) Antimicrobial Agents and Chemotherapy, 54 (9), pp. 3878-3883. Cited 22 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956109968&doi=10.1128%2fAAC.00099-10&partnerID=40&md5=f5796d7d132bf74f8f8f6f74650af4b3
 
DOI: 10.1128/AAC.00099-10
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Schreuder, M.F., Wilhelm, A.J., Bökenkamp, A., Timmermans, S.M.H., Delemarre-van De Waal, H.A., Van Wijk, J.A.E.
Impact of gestational age and birth weight on amikacin clearance on day 1 of life
(2009) Clinical Journal of the American Society of Nephrology, 4 (11), pp. 1774-1778. Cited 24 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73449123001&doi=10.2215%2fCJN.02230409&partnerID=40&md5=61177a6b15a811e82d16fdd8da36a74a
 
DOI: 10.2215/CJN.02230409
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Jelliffe, R., Schumitzky, A., Bayard, D., Leary, R., Botnen, A., Van Guilder, M., Bustad, A., Neely, M.
Human genetic variation, population pharmacokinetic - Dynamic models, Bayesian feedback control, and maximally precise individualized drug dosage regimens
(2009) Current Pharmacogenomics and Personalized Medicine, 7 (4), pp. 249-262. Cited 5 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-73649092728&partnerID=40&md5=817b9c58b4b9b31e6e1d9c2fc1fda962
 
DOCUMENT TYPE: Review
SOURCE: Scopus
 
Eggink, R.N., Duisenberg-van Essenberg, M., Lenderink, A.W.
Volume of distribution of tobramycin in elderly patients [Rekenen met een kleiner verdelingsvolume? Tobramycinedosering bij oudere patiënten]
(2008) Pharmaceutisch Weekblad, 143 (38), pp. 163-166.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-53549111056&partnerID=40&md5=ec38088cb4a6a8ee71c6f0fa66a3590b
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Pullen, J., Stolk, L.M.L., Degraeuwe, P.L.J., Van Tiel, F.H., Neef, C., Zimmermann, L.J.I.
Pharmacokinetics of intravenous rifampicin (rifampin) in neonates
(2006) Therapeutic Drug Monitoring, 28 (5), pp. 654-661. Cited 10 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749817451&doi=10.1097%2f01.ftd.0000245382.79939.a4&partnerID=40&md5=5685645e84a72e0ae34bf27969e4d85c
 
DOI: 10.1097/01.ftd.0000245382.79939.a4
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Stolk, L.M.L., Degraeuwe, P.L.J., Nieman, F.H.M., De Wolf, M.C., De Boer, A.
Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates
(2002) Therapeutic Drug Monitoring, 24 (4), pp. 527-531. Cited 32 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036340609&doi=10.1097%2f00007691-200208000-00011&partnerID=40&md5=1543b29d8a7cc87528fcaf405032731b
 
DOI: 10.1097/00007691-200208000-00011
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Tesfaye, H., Šedivý, J., Morávek, J., Sechser, T.
Impact of therapeutic drug monitoring on further treatment: Retrospective study
(2002) Klinicka Biochemie a Metabolismus, 10 (2), pp. 118-121.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036242690&partnerID=40&md5=6221da5ec3d00935c4d93f92454fc88f
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Hunt, A., Joel, S., Dick, G., Goldman, A.
Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain
(1999) Journal of Pediatrics, 135 (1), pp. 47-55. Cited 56 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033498336&partnerID=40&md5=742416da2038b4c36a51e11a528a3b79
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Gray, R.A., Vander Velde, D.G., Burke, C.J., Manning, M.C., Russell Middaugh, C., Borchardt, R.T.
Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide
(1994) Biochemistry, 33 (6), pp. 1323-1331. Cited 50 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028219636&partnerID=40&md5=cd913a3c73418d39009a802e62aa76bc
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Neef, C., Proost, J.H., Meijer, D.K.F.
Therapeutic drug monitoring with MW/PHARM
(1994) International Journal of Bio-Medical Computing, 36 (1-2), pp. 151-152. Cited 1 time.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028238340&partnerID=40&md5=1f94df9c65519639fc90792e105248d1
 
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Neef, C., Jelliffe, R.W., van Laar, T., Loohuis, T., Guus Essink, A.W., Janssen, E.N.H.
Comparison of two software programs to be used for the calculation of population pharmacokinetic parameters
(1994) International Journal of Bio-Medical Computing, 36 (1-2), pp. 143-150. Cited 3 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028261081&doi=10.1016%2f0020-7101%2894%2990107-4&partnerID=40&md5=1b017702c666dee7d2194b774ab6b310
 
DOI: 10.1016/0020-7101(94)90107-4
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Neef, C., Jelliffe, R.W., van Laar, T., Loohuis, T., Essink, A.W.G., Jansen, E.N.H.
Population Pharmacokinetics of Apomorphine in Patients with Parkinson’s Disease
(1994) Drug Investigation, 7 (4), pp. 183-190. Cited 8 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028328830&doi=10.1007%2fBF03257409&partnerID=40&md5=6a67d6d6a0ce6e91169cd2e4baba39f8
 
DOI: 10.1007/BF03257409
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Neef, C.
Foundation of the users' group MW-PHARM [GEBRUIKERSGROEP MW-PHARM OPGERICHT]
(1990) Pharmaceutisch Weekblad, 125 (31), pp. 785-786.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025164551&partnerID=40&md5=10da8a726a266fe50590650c08f87355
 
DOCUMENT TYPE: Note
SOURCE: Scopus
 
Morisky, D.E., Malotte, C.K., Choi, P., Langer, M., Davidson, P., Rigler, S., Sugland, B.
A Patient Education Program to Improve Adherence Rates with Antituberculosis Drug Regimens
(1990) Health Education & Behavior, 17 (3), pp. 253-266. Cited 114 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025482798&doi=10.1177%2f109019819001700303&partnerID=40&md5=50492f4d8871e723f92c1124c8f2b9be
 
DOI: 10.1177/109019819001700303
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Kaneo, Y., Fujihara, Y., Tanaka, T., Ogawa, K., Fujita, K., Iguchi, S.
Preparation and characterization of a soluble glutathione-dextran conjugate
(1989) International Journal of Pharmaceutics, 57 (3), pp. 263-272. Cited 8 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024843368&doi=10.1016%2f0378-5173%2889%2990216-0&partnerID=40&md5=c8d2efb65cd06baa89526a94bef8fc10
 
DOI: 10.1016/0378-5173(89)90216-0
DOCUMENT TYPE: Article
SOURCE: Scopus
 
Shah, M.V., Audus, K.L., Borchardt, R.T.
The Application of Bovine Brain Microvessel Endothelial-Cell Monolayers Grown onto Polycarbonate Membranes in Vitro to Estimate the Potential Permeability of Solutes Through the Blood–Brain Barrier
(1989) Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, 6 (7), pp. 624-627. Cited 63 times.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024325094&doi=10.1023%2fA%3a1015913817221&partnerID=40&md5=b40e2c01d01bf453b513b8a4fa508fe7